back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-10 13:54 Tx date 2025-01-06 |
$GTTX
Rize Oncology Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+20,526,250 vol |
26,245,074 | |
| Filed 2025-01-10 13:53 Tx date 2025-01-06 |
$GTTX
Rize Oncology Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$695,740,378,825,881
+26,376,891 vol $26,376,891 each |
48,115,810 | |
| Filed 2025-01-09 16:35 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+757,446 vol |
1,529,618 | |
| Filed 2025-01-09 15:11 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Rothman, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,000,000 vol |
4,000,000 | |
| Filed 2025-01-09 15:10 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Rothman, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-09 15:10 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Rothman, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,000
+1,000,000 vol $0.02 each |
1,000,000 | |
| Filed 2025-01-09 15:09 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Rothman, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-09 15:08 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+757,446 vol |
1,629,971 | |
| Filed 2025-01-09 15:07 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,250,000 vol |
1,250,000 | |
| Filed 2025-01-09 15:07 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-09 15:05 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,000
+1,250,000 vol $0.02 each |
3,813,061 | |
| Filed 2025-01-08 18:14 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+757,446 vol |
2,617,410 | |
| Filed 2025-01-08 18:13 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,250,000 vol |
1,360,000 | |
| Filed 2025-01-08 18:12 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$25,000
+1,250,000 vol $0.02 each |
1,385,000 | |
| Filed 2025-01-08 18:11 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+567,383 vol |
1,313,848 | |
| Filed 2025-01-08 18:10 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+1,250,000 vol |
1,305,000 | |
| Filed 2025-01-08 18:08 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$127,967
+6,398,359 vol $0.02 each |
8,829,867 | |
| Filed 2025-01-08 17:50 Tx date 2025-01-06 |
$GTTX
GeneTether Therapeutics Inc. |
O'Neill, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+378,723 vol |
378,723 | |
| Filed 2025-01-02 20:31 Tx date 2024-12-01 |
$GTTX
GeneTether Therapeutics Inc. |
O'Neill, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-24 19:22 Tx date 2024-09-23 |
$GTTX
GeneTether Therapeutics Inc. |
Jull, Gage Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,750
+175,000 vol $0.05 each |
772,172 |